Brief: Gubra Targets Portfolio Of 8-10 Clinical-Stage Assets By 2030
27/10/2026 07:08
BRIEF-Gubra Targets Portfolio Of 8-10 Clinical-Stage Assets By 2030 Oct 27 (Reuters) - Gubra A/S GUBRA.CO:
TARGETS PORTFOLIO OF 8-10 CLINICAL-STAGE ASSETS BY 2030
GUBRA VENTURES AIMS TO LAUNCH AND OPERATE 2-3 VENTURES BY 2030
CRO AIMS TO OUTPERFORM BROADER PRECLINICAL CRO MARKET IN ITS FOCUSED SERVICE AREAS, TARGETING AVERAGE ANNUAL ORGANIC REVENUE GROWTH OF 10% TOWARD 2030
Source text: ID:nMFN6hQwjD
Further company coverage: GUBRA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))